View the AZITHROCIN 500 TABLET registration information details.
Back to drug list
ItemsDrug Registration information
ID2816
No2816
Brand NameAZITHROCIN 500 TABLET
IngredientsAZITHROMYCIN DIHYDRATE 524 MG EQ.TO AZITHROMYCIN USP 500 MG
Dosage FormTABLET
Primary PackagingALU-ALU STRIP
Storage
Shelf Life2 YEARS
Pack SizeBOX OF 3 X 3'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsFOR THE FOLLOWING BACTERIAL INFECTIONS INDUCED BY NICRO-ORGANISMS SUSCEPTIBLE TO AZITHROMYCIN: ACUTE BACTERIAL SINUSITIS (ADEQUATELY DIAGNOSED), ACUTE BACTERIAL OTITIS MEDIA (ADEQUATELY DIAGNOSED), PHARYNGITIS AND TONSILLITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, MILD TO MODERATELY SEVERE COMMUNITY ACQUIRED PNEUMONIA, INFECTION OF THE SKIN AND SOFT TISSUE, UNCOMPLICATED CHLAMYDIA TRACHOMATIS URETHRITIS AND CERVICITIS
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionA BLUE COLORED CAPSULE SHAPE TABLET ENGRAVING DS ON ONE SIDE AND BISECT ON THE OTHER
Note
License OwnerVIMPEX (LAO) CO.,LTD
ManufacturerBEXIMCO PHARMACEUTICALS LIMITED
CountryBANGLADESH
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No10 I 5636/23
FDD Registration Date17/10/2023
Expiry Date16/10/2026
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA